NASD · Healthcare · Biotechnology · USA
Legend Biotech Corp ADR is a mid cap company (market value between $2 billion and $10 billion) in the Biotechnology industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Legend Biotech Corp ADR stock.
Undervalued: intrinsic value $50.44 per share, market price $19.01, margin of safety 62.3% (as of 2026-10-20).
A 7.1x revenue multiple, discounted for its losses, values the shares at $50.44; the price of $19.01 is 62% below that value.
5 more funds hold it; the full list is part of the paid plan.
1 more in this industry show a wider margin of safety.
LEGN is undervalued (as of the 2026-10-20 close). A 7.1x revenue multiple, discounted for its losses, values the shares at $50.44; the price of $19.01 is 62% below that value.
$50.44 per share (as of the 2026-10-20 close), against a market price of $19.01. That is a margin of safety of 62.3%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.